科 研 之 窗
  研究进展
  成果奖励
  病理技术对外服务信息
  流式细胞术分选服务规程
  病理学研究所部分在研的国家级科研项目
  病理学研究所SCI论文目录(2010-2013)

友 情 链 接
     西南医院主页
     校图书馆
     佛图下载
     FTP网站
     西南医院办公系统
更多
  病理学研究所SCI论文目录(2010-2013)

1.Xu C, Xie D, Yu SC, Yang XJ, He LR, Yang J, PingYF, Wang B, Yang L, Xu SL, Cui W, Wang QL, Fu WJ, LiuQ, Qian C, CuiYH,RichJN, KungHF, ZhangX#,Bian XW#. A novel complex of β-catenin/POU5F1/SOX2 is responsive and dependent on IGF-1R signaling for prediction of poor prognosis in lung adenocarcinoma. Cancer Res, 2013, doi:10.1158/0008-5472. CAN-12-4403. Published OnlineFirst March 28, 2013. (SCI, IF 8.65)

2.Yang XJ, Cui W, Gu A, Xu C, SC Yu, Li TT, Cui YH, Zhang X#, Bian XW#. A Novel Zebrafish Xenotransplantation Model to Study Glioma Stem Cell Invasion. PLoS ONE, 2013, 16;8(4):e61801. (SCI, IF 3.73)

3.Yao X, Ping Y, Liu Y, Chen K, Yoshimura T, Liu M, Gong W, Niu Q, Guo D, Zhang X, Wang JM#, Bian XW#. Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by glioma stem-like cells. PLoS ONE, 2013, 8(3): e57188. (SCI, IF 3.73)

4.Duan JJ, Qiu W, Xu SL, Wang B, Ye XZ, Ping YF, Zhang X, Bian XW#, Yu SC#.Strategies for isolating and enriching cancer stem cells: Well begun is half done.Stem Cells Dev, 2013 Mar 29. [Epub ahead of print] (SCI, IF 4.67)

5.Lou W, Chen Q, Ma L, Liu J, Yang Z, Shen J, Cui Y, Bian XW, Qian C#. Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J Mol Med (Berl). 2013 Jan 6. [Epub ahead of print] (SCI, IF4.768)

6.Yang XJ, Chen GL, Yu SC, Xu C, Xin YH, Li TT, Shi Y, Gu A, Duan JJ, Qian C, Cui YH, Zhang X#, Bian XW#. TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model. Int Immunopharmacol, 2012, 15(2):191-198. (SCI, IF 2.659)

7.Ji T, Liu D, Shao W, Yang W, Wu H, Bian X#. Decreased expression of LATS1 is correlated with the progression and prognosis of glioma. J Exp Clin Cancer Res, 2012, 31:67. (SCI, IF 3.066)

8.Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang Bin, Yi Liang, Wang QL, Jiang XF, Yang Lang, Zhang Peng, Qian Cheng, Cui You-hong, Zhang X#, Bian XW#. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol, 2012, 189(1): 444-453. (SCI, IF 5.52)

9.Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, Xu Y, Ma Q, Yang Z, Zhang Q, Ma L, Liu J, Xu S, Yan X, Bie P, Cui Y, Bian XW#, Qian C#. Nanog regulates self-renewal of cancer stem cell through IGF pathway in human hepatocellular carcinoma. Hepatology, 2012, 56(3):1004-1014. (SCI, IF 12.003)

10.Yu SC, Xiao HL, Jiang XF, Wang QL, Li Y, Yang XJ, Ping YF, Duan JJ, Jiang JY, Ye XZ, Xu SL, Xin YH, Yao XH, Chen JH, Chu WH, Sun W, Wang B, Wang JM, Zhang X, Bian XW#. Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells, 2012; 30(2):108-120 (#Corresponding author) (SCI, IF 7.701)

11.Dai HZ, Huang YS, Li Y, Meng G, Wang YQ,Guo QN#.TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma. Carcinogenesis,2012;33(1):30-40. (SCI,IF 5.702)

12.Huang YS,Dai HZ, Guo QN#.TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells. Apoptosis,2012;17:749-761.(SCI,IF 4.788)

13.Yang Z, Zhang QZ, Ke Xu, Juanjuan Shan, Junjie Shen, Limei Liu, Yanmin Xu,Feng Xia, Ping Bie, Xia Zhang, Youhong Cui, Xiu-wu Bian, Cheng Qian# .Combined Therapy with Cytokine-Inducde Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model. PLOS ONE, 2012;7(9): e4802.(SCI, IF 4.092)

14.Wang YQ, Qi XW, Wang F, Jiang J, Guo QN#.Association between TGFBR1 Polymorphisms and Cancer Risk:A meta-Analysis of 35 Case-Control Studies. PLOS ONE, 2012;7(8): e.(SCI, IF 4.092)

15.Wang YQ, Qi XW, Jiang J, Guo QN#.Need clarification of date in the recent meta-analysis about TLR4 polymorphisms and cancer risk. Gene, 2012; 25;508(2):256(SCI, IF 2.341)

16.Cheng L, Tian F, Tang L, Wang S, Chen G, Duan G, Yan X#. Local distribution analysis of cytotoxic molecules in liver allograft is helpful for the diagnosis of acute cellular rejrction after orthotopic liver transplantation. Diagn Pathol, 2012; 30(7):148.(SCI, IF 2.341)

17.Yang L, Ping YF, Yu X, Qian F, Guo ZJ, Qian C, Cui YH#, Bian XW#. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Lett, 2011, 310(1):46-52. (#Co-corresponding author) (SCI, IF 4.258)

18.Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MCM, Chen JH, Wang B, Zhang R, Cui YH, Qian C, Wang JM, Bian XW#. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signaling. J Pathol, 2011, 224(3):344-354 (#Corresponding author) (SCI, IF 7.585)

19.Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM, Bian XW#, Deng YJ#, Ding Y#. HOXB7, a prognostic predictor for colorectal cancer patients, accelerates progression of colorectal cancer. Clin Cancer Res, 2011, 17(11): 3569-3578. (#Co-corresponding author) (SCI, IF 7.837)

20.Ping YF, Bian XW#. Contribution of cancer stem cells to neovascularization. Stem Cells, 2011, 29(6):888-894. (#Co-corresponding author) (SCI, IF 7.701)

21.Wu F, Zhou Q, Yang J, Duan G, Ou J, Zhang R, Pan F, Peng Q, Tan H, Ping YF, Cui Y, Qian C, Yan XC#, Bian XW#. Endogenous axon guiding chemorepulsant Semaphorin-3F inhibits the tumor growth and metastasis of colorectal carcinoma. Clin Cancer Res, 2011, 17(9):2702-2711. (#Co-corresponding author) (SCI, IF 7.837)

22.Wang B, Yu SC, Jiang JY, Porter GW, Zhao LT, Wang Z, Tan H, Cui YH, Qian C, Ping YF#, Bian XW#. A novel inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells. Stem Cell Rev Rep, 2011, 7(2): 458-470 (#Co-corresponding author) (SCI, IF 4.523)

23.Ping YF, Bian XW#. Cancer stem cells switch on tumor neovascularization. Curr Mol Med, 2011 Feb 1;11(1):69-75 (#Corresponding author) (SCI, IF 4.197)
 
24.Yao H, Ng SS, Huo LF, Chow BK, Shen Z, Yang M, Sze J, Ko O, Li M, Yue A, Lu LW, Bian XW, Kung HF, Lin MC#. Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle. Mol Cancer Ther, 2011, 10(6):1082-92. (SCI, IF 5.225)
 
25.Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z, Liu J, Cui Y, Bian X, Bie P, Qian C#. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett, 2011, 310(2):160-169. (SCI, IF 4.864)

26.Ye XQ, Wang GH, Huang GJ, Bian XW, Qian GS, Yu SC#. Heterogeneity of mitochondrial membrane potential: a novel tool to isolate and identify cancer stem cells from a tumor mass? Stem Cell Rev, 2011, 7(1): 153-160 (SCI, IF 3.739)

27.Ye XQ, Li Q, Wang GH, Sun FF, Huang GJ, Bian XW, Yu SC#, Qian GS#. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int J Cancer, 2011, 129(4):820-31 (SCI, IF 4.722)

28.Feng YK,Qing-Hui Yang, Jian-Cheng Xu, Gui-Sheng Qian,Yin-Hu,Liu YS#, Preparation and identification of LBP mimic epitope peptide vaccine.Vaccine, 2011,29:4162-4172. (SCI, IF3.616)

29.Chen R, Fu-Kang Luo, Ya-Li Wang, Jin-Liang Tang, Liu YS#, LBP and CD14 polymorphisms correlate with increased colorectal carcinoma in Han Chinese. World J Gastroenterol, 2011 May 14; 17(18): 2326-2331.(SCI, IF 2.216)

30.Duan GJ, Jiang Zhu, Chen-Yan Xu, Jing-Yuan Wan, Li Zhang, Xiao-Dong Ge, Li-Mei Liu, Liu YS#, PKD inhibitor protectsagainst LPS/D-GalN-induced acute liver injury in mice. Inflammation Research, (2011) 60:357–366.( SCI, IF2.572)

31.Chen Q, Luo W, Shen J, Ma L, Yang Z, Liu L, Luo J, Qian C #. Potent antitumor activity in experimental hepatocellular carcinoma by adenovirus-mediated coexpression of TRAIL and shRNA against COX-2. Clin Cancer Res, 2010;16(14):3696-3705. ( SCI, IF7.742)

32.Duan GJ,jang zhu,jing-yuan wan,xiao-dong ge,li-mei liu, Liu YS#, A synthetic MD-2 mimitic peptide attenuates lipopolysaccharide-induced inflammatory responses in vivo and in vitro. Int Immunopharmacol, 2010,10:1091-1100.(SCI, IF 2.214)

33.Ma L, Liu J, Shen J, Liu L, Wu J, Li W, Luo J, Chen Q, Qian C#. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells.Cancer Biol Ther, 2010;9(7):554-561. (SCI, IF 2.711)

34.Cui YH, Hou X, Chen J, Xie L, Yang L, Le Y. Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes .J Nutr, 2010;140(2):377-381. (SCI, IF 3.916)

35.Duan GJ, Wu F, Zhu J, Guo DY, Zhang R, Shen LL, Wang SH, Li Q, Xiao HL, Mou JH,Yan XC#.Extranodal follicular dendritic cell sarcoma of the pharyngeal region: a potential diagnostic pitfall and literature review Am J Clin Pathol, 2010;133(1):49-58. (SCI, IF 2.598)

36.Du Z, Li J, Wang L, Bian C, Wang Q, Liao L, Dou X, Bian X#, Zhao RC#. Overexpression of ⊿Np63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through notch pathway. Cancer Sci, 2010, 101(11): 2417-2424 (#Co-corresponding author) (SCI, IF 3.479)

37.Xu CP, Zhang HR, Chen FL, Liang ZQ, Zhang R, Cui Y, Qian C, Bian XW#. Human malignant glioma cells expressing functional formylpeptide receptor recuit endothelial progenitor cells for neovascularization. Int Immunopharmacol, 2010, 10(12):1602-1607 (#Corresponding author) (SCI, IF 2.417)
 
38.Ye XZ, Yu SC#, Bian XW#. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis. J Genet Genomics, 2010, 37(7): 423-430 (#Co-corresponding author) (SCI, IF 2.076)

39.Xiao HL, Eyden B, Yan XC, Wang Yi, Zhang Rong, Bian XW#. Intraparenchymal myofibromatosis of the brain in an adult: report of an unusual case. Neuropathology, 2010, 30(3): 288-293 (#Corresponding author) (SCI, IF 1.909)

40.Liu L, Tian Y, Gao N, Chen Zt, Zhang H, An J. Application of antibodies against nonstructural protein 2B of dengue serotype 2 virus induced by DNA immunisation or recombinant protein NS. J Virol Methods, (SCI, IF 2.133)

41.Feng YK, Yang QH, Liu YS, Xu JC, Qian GS, Wang YH. The localization of two mimic epitopes of lipopolysaccharide binding protein and the preparation of their tandem multiple antigen peptide. J Immunol Methods, (SCI, IF 2.203)

42.Yao XH, Ping YF, Bian XW#. Contribution of cancer stem cells to tumor vasculogenic mimicry. Protein Cell, 2011, 2(4):266-272. (SCI, IF 3.22 )

43.Zhou ZH, Ping YF, Yu SC, Yi L, Yao XH, Bian XW#. A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line. Cancer Lett, 2009, 281:92-99 (#Corresponding author) (SCI, IF 4.258)

44.Yu SC, Bian XW#. Enrichment of cancer stem cells based on heterogeneity of invasiveness. Stem Cell Rev Rep, 2009, 5(1): 66-71 (#Corresponding author) (SCI, IF 4.523)

45.Chen DL, Ping YF, Yu SC, Chen JH, Yao XH, Jiang XF, Zhang HR, Wang QL,  Bian XW#. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells. Biochem Biophys Res Commun, 2009, 381(3):448-452 (#Corresponding author) (SCI, IF 2.406)

46.Zhang HR, Chen FL, Xu CP, Ping YF, Wang QL, Liang ZQ, Wang JM, Bian XW#. Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft. J Neuro-oncol, 2009, 93(2): 165-174 (#Corresponding author) (SCI, IF 3.115)

47.Bian XW#, Xu JP, Ping YF, Wang Y, Chen JH, Xu CP, Wu YZ, Wu J, Zhou XD, Chen YS, Shi JQ, Wang JM. Unique proteomic features induced by a potential anti-glioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells. Proteomics, 2008, 8(3): 484-494 (#Corresponding author) (SCI, IF 4.132)

48.Yao XH, Ping YF, Chen JH, Xu CP, Chen DL, Zhang R, Wang JM, Bian XW#. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol, 2008, 215(4): 369-376 (#Corresponding author) (SCI, IF 7.585)

49.Yao XH, Ping YF, Chen JH, Xu CP, Chen DL, Wang JM, Bian XW#. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J Neuro-oncol, 2008, 86(1):47-53 (#Corresponding author) (SCI, IF 3.115)

50.Bian XW#, Xiao HL, Yang SX, Wang JM. Preferential expression of the chemokine receptor CXCR4 by more highly malignant human gliomas and association with poor patient survival (Correspondence). Neurosurgery, 2008, 63(4): E820 (#Corresponding author) (SCI, IF 2.532)

51.Yi L, Zhou ZH, Ping YF, Chen JH, Yao XH, Lu JY, Feng H, Wang JM, Bian XW#. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Modern Pathol, 2007, 20(10): 1061-1068. (#Corresponding author) (SCI, IF 5.253)

52.Chen JH, Yao XH, Gong W, Hu J, Zhou XD , Chen K, Liu H, Ping YF, Wang JM, Bian XW#. A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors. J Neuro-oncol, 2007, 84(3):223-231 (#Corresponding author) (SCI, IF 3.115).

53.Ping YF, Yao XH, Chen JH, Liu H, Chen DL, Zhou XD, Wang JM, Bian XW#. The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells. J Neuro-oncol, 2007, 84(1): 21-29 (#Corresponding author) (SCI, IF 3.115)

54.Bian XW#, Jiang XF, Chen JH, Bai JS, Dai C, Wang QL, Lu JY, Zhao W, Xin R, Liu MY, Shi JQ, Wang JM. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol, 2006, 6(1): 90-99 (#Corresponding author) (SCI, IF 2.417)

55.Bian XW#, Wang QL, Xiao HL, Wang JM. Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology. J Neuro-oncol, 2006, 80(2): 211-213 (#Corresponding author) (SCI, IF 3.115)

56.Chen JH, Bian XW#, Yao XH, Gong W, Hu J, Chen K, Irebarrin P, Zhao W, Zhou XD. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor (FPR) and induces differentiation of malignant glioma cells. Biochem Biophys Res Commun, 2006, 342(4): 1368-1374 (#Corresponding author) (SCI, IF 2.406)

57.Zhou Y*, Bian X*, Le Y, Gong W, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wang JM. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J. Natl. Cancer Inst., 2005; 97(11): 823-835 (*equal contribution)(SCI, IF 14.336)

58.Yang SX, Chen JH, Jiang XF, Wang QL, Chen ZQ, Zhao W, Feng YH, Xin R, Shi JQ, Bian XW#. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Commun, 2005, 335(2): 523-528 (#Corresponding author) (SCI, IF 2.406)

59.Bian XW#, Chen JH, Jiang XF, Bai JS, Zhang X#. Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol., 2004,4(12): 1537-1547 (invited review) (#Co-corresponding author) (SCI, IF 2.468)

60.Bian XW#, Shi JQ, Liu FX. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors. Anal Quant Cytol Histol, 2000, 22(6):429-37 (SCI,0.6) (#Corresponding author)

61.Bian XW#, Du LL, Shi JQ, Cheng YS, Liu FX. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol, 2000, 22(3):267-274 (SCI,0.6) (#Corresponding author)

西南医院·病理学研究所 中国·重庆市沙坪坝区高滩岩正街30号 邮编:400038 
Email:blk@swhospital.com